Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013, Article ID 650989, 9 pages
http://dx.doi.org/10.1155/2013/650989
Review Article

Lipoprotein(a) in Cardiovascular Diseases

1International Ph. D. Program in Neuropharmacology, University of Catania, 95123 Catania, Italy
2Department of Senescence, Urological, and Neurological Sciences, University of Catania, 95126 Catania, Italy
3Department of Biomedical Sciences, University of Catania, 95124 Catania, Italy
4Department of Neurosciences, University of Catania, 95123 Catania, Italy
5Department of Biological Chemistry, Medical Chemistry, and Molecular Biology, University of Catania, 95123 Catania, Italy
6Pediatric Cardiology and Cardiac Surgery Department, Guch Unit, IRCCS Policlinico San Donato, 20097 Milan, Italy

Received 6 September 2012; Revised 6 November 2012; Accepted 8 November 2012

Academic Editor: Joseph Fomusi Ndisang

Copyright © 2013 Michele Malaguarnera et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [38 citations]

The following is the list of published articles that have cited the current article.

  • Bobby Yanagawa, Nandini Gupta, and Subodh Verma, “A genetic advance: Lipoprotein(a) in aortic stenosis,” Clinical Lipidology, vol. 8, no. 3, pp. 307–309, 2013. View at Publisher · View at Google Scholar
  • Samuel Henrique Vieira Oliveira, Marciano Robson de Miranda, Charles Augusto dos Santos Morais, András Palotás, and Luciana Moreira Lima, “Serum lipoprotein-A levels in healthy subjects indicate a lurking cerebro- and cardio-vascular risk in the younger population,” Brain Research Bulletin, 2013. View at Publisher · View at Google Scholar
  • Lijuan Ma, Jia Wu, Dongmei Niu, Ruijie Yu, Jiaxi Song, Chunni Zhang, and Junjun Wang, “Serum lipoprotein(a) complexes with beta2-glycoprotein I levels in patients with ischemic stroke,” Clinica Chimica Acta, 2013. View at Publisher · View at Google Scholar
  • Taratukhin, “Plasminogen activators in acute management of thrombosis,” Russian Journal of Cardiology, vol. 101, no. 3, pp. 81–84, 2013. View at Publisher · View at Google Scholar
  • Valmore Bermúdez, Joselyn Rojas, Juan Salazar, Luis Bello, Roberto Áñez, Alexandra Toledo, Maricarmen Chacín, Miguel Aguirre, Marjorie Villalobos, Mervin Chávez, María Sofía Martínez, Wheeler Torres, Yaquelin Torres, José Mejías, Edgardo Mengual, Liliana Rojas, Milagro Sánchez de Rosales, Ana Quevedo, Raquel Cano, Mayela Cabrera, Rafael París, Adonías Lubo, María Montiel, and Climaco Cano, “Variations of Lipoprotein(a) Levels in the Metabolic Syndrome: A Report from the Maracaibo City Metabolic Syndrome Prevalence Study,” Journal of Diabetes Research, vol. 2013, pp. 1–12, 2013. View at Publisher · View at Google Scholar
  • Giulia Malaguarnera, Caterina Gagliano, Claudio Bucolo, Marco Vacante, Salvatore Salomone, Michele Malaguarnera, Daniela Giovanna Leonardi, Massimo Motta, Filippo Drago, and Teresio Avitabile, “Lipoprotein(a) Serum Levels in Diabetic Patients with Retinopathy,” BioMed Research International, vol. 2013, pp. 1–5, 2013. View at Publisher · View at Google Scholar
  • Berta Esteban-Fernandez de Avila, Susana Campuzano, Maria Pedrero, J-Pablo Salvador, M-Pilar Marco, and Jose M. Pingarron, “Lipoprotein(a) determination in human serum using a nitrilotriacetic acid derivative immunosensing scaffold on disposable electrodes,” Analytical and Bioanalytical Chemistry, vol. 406, no. 22, pp. 5379–5387, 2014. View at Publisher · View at Google Scholar
  • Mohsen Naseri, Mehdi Hedayati, Maryam Sadat Daneshpour, Fatemeh Bandarian, and Fereidoun Azizi, “Identification of genetic variants of lecithin cholesterol acyltransferase in individuals with high HDL-C levels,” Molecular Medicine Reports, vol. 10, no. 1, pp. 496–502, 2014. View at Publisher · View at Google Scholar
  • Zhaoyang Li, Marjie L. Hard, Grit Andersen, Guenther Pabst, Gilbert Wagener, Tejdip Singh, Wai Chin, Kerry Culm-Merdek, Ingrid Boltje, and Lisa L. von Moltke, “Pharmacokinetics, safety and tolerability of mipomersen in healthy Japanese volunteers and comparison with Western subjects,” International Journal of Clinical Pharmacology and Therapeutics, vol. 52, no. 4, pp. 314–320, 2014. View at Publisher · View at Google Scholar
  • Miriam Koch, and Alma Zernecke, “The hemostatic system as a regulator of inflammation in atherosclerosis,” IUBMB Life, 2014. View at Publisher · View at Google Scholar
  • Samy Ali Hussein, Omnia M. Abd El-Hamid, and Haidy S. Hemdan, “Protective effect of l-carnitine on metabolic disorders, oxidative stress, antioxidant status and inflammation in a rat model of insulin resistance,” International Journal of Biological Chemistry, vol. 8, no. 1, pp. 21–36, 2014. View at Publisher · View at Google Scholar
  • Masataka Kusunoki, Kazuhiko Tsutsumi, Daisuke Sato, Tetsuro Miyata, and Takao Nakamura, “Effects of Fasting on Plasma Lipoprotein(a) in Cynomolgus Monkeys: Preliminary Experiments Results,” Open Journal of Animal Sciences, vol. 04, no. 05, pp. 222–227, 2014. View at Publisher · View at Google Scholar
  • P.R. Criado, D.P.S. Espinell, P. Barreto, T.H.B. Di Giacomo, and M.N. Sotto, “Lipoprotein(a) and livedoid vasculopathy: A new thrombophilic factor?,” Medical Hypotheses, 2015. View at Publisher · View at Google Scholar
  • Giulia Malaguarnera, Massimo Motta, Caterina Gagliano, Salvatore Salomone, Maria Giordano, Claudio Bucolo, Antonino Pappalardo, Filippo Drago, Filippo Caraci, and Teresio Avitabile, “Folate status in type 2 diabetic patients with and without retinopathy,” Clinical Ophthalmology, vol. 9, pp. 1437–1442, 2015. View at Publisher · View at Google Scholar
  • E. Groß, B. Hohenstein, and U. Julius, “Effects of Lipoprotein apheresis on the Lipoprotein(a) levels in the long run,” Atherosclerosis Supplements, vol. 18, pp. 226–232, 2015. View at Publisher · View at Google Scholar
  • S. Tselmin, G. Müller, E. Gelgaft, S. Fischer, and U. Julius, “An elevated lipoprotein(a) plasma level as a cardiovascular risk factor,” Atherosclerosis Supplements, vol. 18, pp. 257–262, 2015. View at Publisher · View at Google Scholar
  • Fernando Andrade, Alicia Sanchez-Ortega, Marta Llarena, Sergio Pinar-Sueiro, Marta Galdos, M. Aranzazu Goicolea, Ramon J. Barrio, and Luis Aldamiz-Echevarria, “Metabolomics in non-arteritic anterior ischemic optic neuropathy patients by liquid chromatography-quadrupole time-of-flight mass spectrometry,” Metabolomics, vol. 11, no. 2, pp. 468–476, 2015. View at Publisher · View at Google Scholar
  • Camilla Mattiuzzi, Gianfranco Cervellin, and Giuseppe Lippi, “Epidemiological association between migraine and lipoprotein(a): a systematic review,” Journal Of Thrombosis And Thrombolysis, vol. 39, no. 1, pp. 113–117, 2015. View at Publisher · View at Google Scholar
  • M. Florentin, M. S. Elisaf, C. V. Rizos, V. Nikolaou, E. Bilianou, C. Pitsavos, and E. N. Liberopoulos, “l-Carnitine/Simvastatin Reduces Lipoprotein (a) Levels Compared with Simvastatin Monotherapy: A Randomized Double-Blind Placebo-Controlled Study,” Lipids, 2016. View at Publisher · View at Google Scholar
  • Giulia Malaguarnera, Vito Emanuele Catania, Antonio Francaviglia, Michele Malaguarnera, Filippo Drago, Massimo Motta, and Saverio Latteri, “Lipoprotein(a) in patients with hepatocellular carcinoma and portal vein thrombosis,” Aging Clinical and Experimental Research, 2016. View at Publisher · View at Google Scholar
  • Kevin P. Bliden, Udaya S. Tantry, Martin G. Gesheff, Christopher J. Franzese, Shachi Pandya, Peter P. Toth, Denny P. Mathew, Rahul Chaudhary, and Paul A. Gurbel, “Thrombin-Induced Platelet-Fibrin Clot Strength Identified by Thrombelastography,” Journal of Interventional Cardiology, 2016. View at Publisher · View at Google Scholar
  • Giuseppe Chisari, Carmen Greco, Edoardo Stagni, Liborio Rampello, Eleonora Margherita Chisari, Vito Emanuele Catania, and Clara Grazia Chisari, “Microbiology synergism between tear substitutes and symbiotic treatment of patients with irritable bowel syndrome,” Acta Medica Mediterranea, vol. 32, no. 4, pp. 865–870, 2016. View at Publisher · View at Google Scholar
  • Przemysław Nowacki, Dariusz Kotlȩga, Monika Gołab-Janowska, Marta Masztalewicz, and Sylwester Ciećwiez, “Association between selected gene polymorphisms and statin metabolism, risk of ischemic stroke and cardiovascular disorders,” Postepy Higieny i Medycyny Doswiadczalnej, vol. 70, pp. 435–447, 2016. View at Publisher · View at Google Scholar
  • Vera Gessi, Rossella Marcucci, Massimo Franchini, Francesco Dentali, Monica Gianni, and Anna Maria Grandi, “Lipoprotein(a) as a Risk Factor for Venous Thromboembolism: A Systematic Review and Meta-analysis of the Literature,” Seminars in Thrombosis and Hemostasis, vol. 43, no. 6, pp. 614–620, 2017. View at Publisher · View at Google Scholar
  • Saverio Latteri, Vito Emanuele Catania, Giulia Malaguarnera, and Michele Malaguarnera, “Reduction of cardiovascular risk in subjects with high lipoprotein (a) levels,” Journal of Thoracic Disease, vol. 9, no. 8, pp. 2332–2336, 2017. View at Publisher · View at Google Scholar
  • Gianna Ferretti, Tiziana Bacchetti, Thomas P. Johnston, Maciej Banach, Matteo Pirro, and Amirhossein Sahebkar, “Lipoprotein(a): A missing culprit in the management of athero-thrombosis?,” Journal of Cellular Physiology, 2017. View at Publisher · View at Google Scholar
  • Valmore Berm?dez, Juan Salazar, Mar?a Calvo, Mar?a Mart?nez, Roberto A?ez, Jos? Rivas-R?os, Maricarmen Chac?n, Juan Hern?ndez, Modesto Graterol, and Joselyn Rojas, “Importance of high triglycerides levels between novel coronary risk factors,” Revista Colombiana de Cardiolog?a, 2017. View at Publisher · View at Google Scholar
  • Paththinige, Sirisena, and Dissanayake, “Genetic determinants of inherited susceptibility to hypercholesterolemia - a comprehensive literature review,” Lipids in Health and Disease, vol. 16, no. 1, 2017. View at Publisher · View at Google Scholar
  • X Decai, Z Zhiyong, Z Bin, H Zhongcheng, W Quanshu, and L Jing, “Correlation Analysis of Relative Expression of Apob, Adfp and Fatp1 with Lipid Metabolism in Daweishan Mini Chickens,” Revista Brasileira de Ciência Avícola, vol. 19, no. 1, pp. 151–158, 2017. View at Publisher · View at Google Scholar
  • J.T. Neumann, and R.B. Schnabel, “Biomarkers in Ischemic Heart Disease,” Reference Module in Biomedical Sciences, 2017. View at Publisher · View at Google Scholar
  • Alexandra Foscolou, Ekavi Georgousopoulou, Emmanouella Magriplis, Nenad Naumovski, Loukianos Rallidis, Antonia-Leda Matalas, Christina Chrysohoou, Dimitrios Tousoulis, Christos Pitsavos, and Demosthenes Panagiotakos, “The mediating role of Mediterranean diet on the association between Lp(a) levels and cardiovascular disease risk: A 10-year follow-up of the ATTICA study,” Clinical Biochemistry, 2018. View at Publisher · View at Google Scholar
  • Nyayapathi Venkata Balakrishna Sai, Gadepalli Ramesh, Pramod Gururaj, Reddy Bhupal, and Nilesh Patel, “Association of metabolic syndrome and level of hs-CRP, Lp(a), and serum ferritin in young Asian patients (≤45 years) with acute myocardial infarction,” Interventional Medicine and Applied Science, vol. 10, no. 2, pp. 65–69, 2018. View at Publisher · View at Google Scholar
  • Alaa Badawi, Giancarlo Di Giuseppe, and Paul Arora, “Cardiovascular disease risk in patients with hepatitis C infection: Results from two general population health surveys in Canada and the United States (2007-2017),” Plos One, vol. 13, no. 12, pp. e0208839, 2018. View at Publisher · View at Google Scholar
  • Malaguarnera Mariangela, Catania Vito Emanuele, Borzì Antonio Maria, Malaguarnera Stefano, Madeddu Roberto, Bertino Gaetano, and Latteri Saverio, “Blood Homocysteine levels are increased in Hepatocellular carcinoma patients with portal vein thrombosis. A single centre retrospective cohort study,” International Journal of Surgery Open, 2018. View at Publisher · View at Google Scholar
  • Weijie Violet Lin, Aroucha Vickers, Claudia M. Prospero Ponce, and Andrew G. Lee, “Elevated lipoprotein(a) levels as the cause of cryptogenic stroke in a young Ashkenazi Jewish female,” Canadian Journal of Ophthalmology, 2018. View at Publisher · View at Google Scholar
  • J.T. Neumann, and R.B. Schnabel, “Biomarkers in Ischemic Heart Disease,” Encyclopedia of Cardiovascular Research and Medicine, pp. 303–314, 2018. View at Publisher · View at Google Scholar
  • Elisa Gravito-Soares, Pedro Figueiredo, Marta Gravito-Soares, and Luis Tomé, “Acute-on-chronic mesenteric ischaemia by early and diffuse atherosclerosis in a young adult patient,” BMJ Case Reports, vol. 2018, 2018. View at Publisher · View at Google Scholar
  • Young-Hwa Goo, “Cholesterol Metabolism in Atherosclerosis Development,” The Molecular Nutrition of Fats, pp. 299–306, 2019. View at Publisher · View at Google Scholar